Get notified when TWAV files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TWAV TaoWeave, Inc. 10-Q

TaoWeave pivots to Bittensor staking, ends Mezzanine product line, strips MD&A detail

Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read

Key Changes

  • high

    Company announced end-of-life for Mezzanine collaboration products in December 2025, expects no product revenue and only minor maintenance revenue for remainder of 2026, marking formal exit from legacy business.

    Risk Factors: Mezzanine end-of-life verify on EDGAR →
  • high

    Company now stakes substantially all TAO tokens through third-party custodians and validators, relies on selling TAO to fund operations, but has no committed credit facilities and faces liquidity risk from volatile TAO prices and limited exchange liquidity.

    Risk Factors: TAO liquidity and conversion verify on EDGAR →
  • high

    MD&A section stripped of all quarterly financial results, segment performance tables, and operating expense breakdowns; replaced with brief boilerplate on accounting estimates, eliminating operational transparency.

    MD&A: segment results removed verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.

Partner

Trade TWAV commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify